Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcelo Silva

Showing results (161-170 of 207) with videos related to

Pageof 21
Sort By:
Scientific Reports|April 21, 2025
Genome-wide association analysis reveals insights into the genetic architecture of mesenteric torsion in pigsSuelen Fernandes Padilha, Rafaela Martins, Ludmila Mudri Hul, et al.
Gastroenterology|February 12, 2009
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapyThierry Poynard, Massimo Colombo, Jordi Bruix, et al.
Journal of Hepatology|November 9, 2010
FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ programThierry Poynard, Mona Munteanu, Massimo Colombo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 10, 2025
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated CirrhosisFederico Piñero, Margarita Anders, Carla Bermudez, et al.
Proteomics|July 24, 2018
FGF2 Antiproliferative Stimulation Induces Proteomic Dynamic Changes and High Expression of FOSB and JUNB in K-Ras-Driven Mouse Tumor CellsFrancisca Nathalia de Luna Vitorino, Fabio Montoni, Jaqueline Neves Moreno, et al.
Microbiology Spectrum|April 17, 2023
<i>Brevundimonas brasiliensis</i> sp. nov.: a New Multidrug-Resistant Species Isolated from a Patient in BrazilGabriela Guerrera Soares, Emeline Boni Campanini, Roumayne Lopes Ferreira, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 24, 2017
Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimensK Rajender Reddy, Stanislas Pol, Paul J Thuluvath, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 13, 2016
Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin AmericaFederico Piñero, Matías Tisi Baña, Elaine Cristina de Ataide, et al.
BMC Infectious Diseases|July 30, 2025
Impact of post-COVID-19 syndrome on quality of life and functionality in ethnically diverse and vulnerable populations in the AmazonMarcelo Silva de Paula, Sheyla Mara Silva de Oliveira, Tatiane Costa Quaresma, et al.
Clinics and Research in Hepatology and Gastroenterology|May 19, 2018
A changing etiologic scenario in liver transplantation for hepatocellular carcinoma in a multicenter cohort study from Latin AmericaFederico Piñero, Paulo Costa, Yuri Longatto Boteon, et al.
Pageof 21

Showing results (161-170 of 207) with videos related to

Sort By:
Pageof 21
Scientific Reports|April 21, 2025
Genome-wide association analysis reveals insights into the genetic architecture of mesenteric torsion in pigsSuelen Fernandes Padilha, Rafaela Martins, Ludmila Mudri Hul, et al.
Gastroenterology|February 12, 2009
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapyThierry Poynard, Massimo Colombo, Jordi Bruix, et al.
Journal of Hepatology|November 9, 2010
FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ programThierry Poynard, Mona Munteanu, Massimo Colombo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 10, 2025
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated CirrhosisFederico Piñero, Margarita Anders, Carla Bermudez, et al.
Proteomics|July 24, 2018
FGF2 Antiproliferative Stimulation Induces Proteomic Dynamic Changes and High Expression of FOSB and JUNB in K-Ras-Driven Mouse Tumor CellsFrancisca Nathalia de Luna Vitorino, Fabio Montoni, Jaqueline Neves Moreno, et al.
Microbiology Spectrum|April 17, 2023
<i>Brevundimonas brasiliensis</i> sp. nov.: a New Multidrug-Resistant Species Isolated from a Patient in BrazilGabriela Guerrera Soares, Emeline Boni Campanini, Roumayne Lopes Ferreira, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 24, 2017
Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimensK Rajender Reddy, Stanislas Pol, Paul J Thuluvath, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 13, 2016
Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin AmericaFederico Piñero, Matías Tisi Baña, Elaine Cristina de Ataide, et al.
BMC Infectious Diseases|July 30, 2025
Impact of post-COVID-19 syndrome on quality of life and functionality in ethnically diverse and vulnerable populations in the AmazonMarcelo Silva de Paula, Sheyla Mara Silva de Oliveira, Tatiane Costa Quaresma, et al.
Clinics and Research in Hepatology and Gastroenterology|May 19, 2018
A changing etiologic scenario in liver transplantation for hepatocellular carcinoma in a multicenter cohort study from Latin AmericaFederico Piñero, Paulo Costa, Yuri Longatto Boteon, et al.
Pageof 21